These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16601641)

  • 41. Sleep disorders in children with Attention-Deficit/Hyperactivity Disorder (ADHD) recorded overnight by video-polysomnography.
    Silvestri R; Gagliano A; Aricò I; Calarese T; Cedro C; Bruni O; Condurso R; Germanò E; Gervasi G; Siracusano R; Vita G; Bramanti P
    Sleep Med; 2009 Dec; 10(10):1132-8. PubMed ID: 19527942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies.
    Cohen-Zion M; Ancoli-Israel S
    Sleep Med Rev; 2004 Oct; 8(5):379-402. PubMed ID: 15336238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic Ritalin use and cancer.
    Goldstein S
    J Atten Disord; 2010 Mar; 13(5):441. PubMed ID: 20190147
    [No Abstract]   [Full Text] [Related]  

  • 45. Combining methylphenidate and clonidine: a clinically sound medication option.
    Wilens TE; Spencer TJ; Swanson JM; Connor DF; Cantwell D
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):614-9; discussion 619-22. PubMed ID: 10230195
    [No Abstract]   [Full Text] [Related]  

  • 46. Reboxetine use in the treatment of attention-deficit/hyperactivity disorder.
    Cak HT; Cetin FC
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):803-4. PubMed ID: 17201625
    [No Abstract]   [Full Text] [Related]  

  • 47. Methylphenidate-Induced Nocturnal Bruxism Alleviated by Adjunctive Clonidine.
    Naguy A; Elsori D; Alamiri B
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):75-76. PubMed ID: 30575406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Attention deficit disorder with hyperactivity in children: diagnosis and therapeutic management].
    Vallée L
    Arch Pediatr; 2000 Oct; 7(10):1111-6. PubMed ID: 11075268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methylphenidate-induced "Moving Ear Syndrome" in a child with ADHD responding favorably to add-on propranolol.
    Naguy A; Alrashidi F; Elsori DH
    Asia Pac Psychiatry; 2019 Mar; 11(1):e12347. PubMed ID: 30474193
    [No Abstract]   [Full Text] [Related]  

  • 50. Stuttering Associated With the Use of Short-Acting Oral Methylphenidate.
    Alpaslan AH; Coşkun KŞ; Kocak U; Gorücü Y
    J Clin Psychopharmacol; 2015 Dec; 35(6):739-41. PubMed ID: 26436866
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of withdrawal of Ritalin LA in the Western Cape.
    Donker Fv; Riordan G; Wilmshurst J
    S Afr Med J; 2008 Aug; 98(8):570. PubMed ID: 18928026
    [No Abstract]   [Full Text] [Related]  

  • 52. Psychopharmacology for the clinician: management of comorbid Tourette syndrome and attention-deficit/hyperactivity disorder: are psychostimulants an option?
    Pringsheim T
    J Psychiatry Neurosci; 2012 Nov; 37(6):432. PubMed ID: 23092593
    [No Abstract]   [Full Text] [Related]  

  • 53. ADHD drugs and cardiovascular risk.
    Anders T; Sharfstein S
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16723628
    [No Abstract]   [Full Text] [Related]  

  • 54. Excessive and Frequent Menstrual Bleeding With Methylphenidate in an Adolescent Girl With Attention-Deficit Hyperactivity Disorder.
    Coskun M; Adak I
    J Clin Psychopharmacol; 2017 Oct; 37(5):637-639. PubMed ID: 28719424
    [No Abstract]   [Full Text] [Related]  

  • 55. ADHD, growth deficits, and relationships to psychostimulant use.
    Joshi SV
    Pediatr Rev; 2002 Feb; 23(2):67-8; discussion 67-8. PubMed ID: 11826259
    [No Abstract]   [Full Text] [Related]  

  • 56. Methylphenidate role in Tourette syndrome prevalence.
    Millichap JG
    J R Soc Med; 1999 Mar; 92(3):156. PubMed ID: 10396274
    [No Abstract]   [Full Text] [Related]  

  • 57. Lymphomatoid drug reaction secondary to methylphenidate hydrochloride.
    Welsh JP; Ko C; Hsu WT
    Cutis; 2008 Jan; 81(1):61-4. PubMed ID: 18306850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A chart review of cyproheptadine for stimulant-induced weight loss.
    Daviss WB; Scott J
    J Child Adolesc Psychopharmacol; 2004; 14(1):65-73. PubMed ID: 15142393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-Dependent Enuresis in Methylphenidate Use.
    Güleşen O; Bodur Ş; Cöngöloğlu A
    Clin Neuropharmacol; 2022 Nov-Dec 01; 45(6):184-186. PubMed ID: 36314572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term safety of methylphenidate in children with ADHD.
    Moran LV
    Lancet Psychiatry; 2023 May; 10(5):306-307. PubMed ID: 36958361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.